MENU
Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Sep 10, 2023

Stay Profitable in Volatile Markets: Tickeron's Best Robot of the Week Delivers 59% Annualized Return and 1.7 Sharpe Ratio!

We can all agree that the past week has been a rollercoaster ride for traders. With major US stock market indexes experiencing drops ranging from -0.71 percent to -3.63 percent, it's clear that navigating market turbulence demands a sophisticated trading approach. That's why we're excited to introduce Tickeron's best-performing algorithm of the week, a true beacon of stability and consistent results.

Swing Trader: Medium Volatility Stocks for Active Trading (TA&FA)

Click to view full description and closed trades for free!

In times of sharp corrections like these, the ability to accurately assess market volatility and manage risks effectively becomes paramount. Tickeron's cutting-edge algorithm is precisely crafted to do just that, offering you the confidence you need in today's challenging trading environment.

What sets our top robot apart is its remarkable Sharpe ratio of 1.7, a testament to its ability to deliver consistent returns while efficiently managing risk. This stability and reliability are what every trader seeks, especially in unpredictable markets.

Click to view full description and closed trades for free!

Key highlights of Tickeron's top-performing algorithm:

  1. Stability and Consistency: This AI robot is tailor-made for traders who prefer stocks with medium volatility while aiming to avoid significant drawdowns during downtrends. How does it achieve this feat? By utilizing a well-crafted arsenal of technical indicators focused on identifying uptrend reversal points. This balanced approach enables the robot to navigate both short and long positions skillfully, reducing the risk of prolonged drawdowns.
  2. Precise Risk Management: What sets our robot apart is its proprietary method, developed by our team of quantitative analysts, which assesses the strength and quality of momentum in the most active stocks within the US market. Using a complex algorithm, this process involves a pool of technical indicators, meticulously analyzed through neural networks, to determine precise entry points for positions.
  3. Proven Results: Backed by a high Sharpe ratio of 1.7, our algorithm consistently delivers impressive results.

Navigating the market's ups and downs requires a trusted companion by your side, and Tickeron's algorithm is that reliable partner. It excels in identifying opportunities while protecting your investments, allowing you to focus on your trading strategies without the anxiety of market volatility.

Stay ahead of market turbulence with Tickeron - your path to stability and consistent results!

Here are the latest trades:

Related Ticker: SAVA, PHUN, BLNK, ACAD

SAVA's RSI Indicator ascending out of oversold territory

The RSI Oscillator for SAVA moved out of oversold territory on February 04, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 30 similar instances when the indicator left oversold territory. In of the 30 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 10 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where SAVA advanced for three days, in of 247 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on January 21, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on SAVA as a result. In of 76 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SAVA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

SAVA broke above its upper Bollinger Band on January 03, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for SAVA entered a downward trend on January 02, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.690) is normal, around the industry mean (15.863). P/E Ratio (0.000) is within average values for comparable stocks, (89.961). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.849). SAVA has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (0.000) is also within normal values, averaging (271.343).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. SAVA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SAVA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

Notable companies

The most notable companies in this group are Regeneron Pharmaceuticals (NASDAQ:REGN), Incyte Corp (NASDAQ:INCY), Moderna (NASDAQ:MRNA), Sarepta Therapeutics (NASDAQ:SRPT), Exelixis (NASDAQ:EXEL), Arrowhead Pharmaceuticals (NASDAQ:ARWR), BioCryst Pharmaceuticals (NASDAQ:BCRX), Novavax (NASDAQ:NVAX), Adaptive Biotechnologies Corp (NASDAQ:ADPT), Nektar Therapeutics (NASDAQ:NKTR).

Industry description

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

Market Cap

The average market capitalization across the Biotechnology Industry is 2.45B. The market cap for tickers in the group ranges from 58 to 368.44B. NONOF holds the highest valuation in this group at 368.44B. The lowest valued company is SEELQ at 58.

High and low price notable news

The average weekly price growth across all stocks in the Biotechnology Industry was 5%. For the same Industry, the average monthly price growth was 1%, and the average quarterly price growth was 14%. IVVD experienced the highest price growth at 202%, while VIRX experienced the biggest fall at -79%.

Volume

The average weekly volume growth across all stocks in the Biotechnology Industry was -24%. For the same stocks of the Industry, the average monthly volume growth was -2% and the average quarterly volume growth was 139%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 85
Price Growth Rating: 66
SMR Rating: 94
Profit Risk Rating: 94
Seasonality Score: -35 (-100 ... +100)
View a ticker or compare two or three
PHUN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of mobile applications

Industry PackagedSoftware

Profile
Fundamentals
Details
Industry
Packaged Software
Address
1002 West Avenue
Phone
+1 512 693-4199
Employees
25
Web
https://www.phunware.com